Baxter Extraneal Hypoglycemia Testing Program Is Condition Of FDA Approval
Executive Summary
Baxter will initiate an Extraneal physician and patient educational campaign to help avoid falsely elevated glucose tests following FDA approval of the peritoneal dialysis solution